查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679355

北美數位病理學市場規模、佔有率、趨勢分析報告（按應用、產品、最終用途、國家/地區、細分市場預測，2025 年至 2030 年）

North America Digital Pathology Market Size, Share & Trends Analysis Report By Application, By Product, By Type, By End Use, By Country, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

北美數位病理學市場的成長和趨勢

預計到 2030 年北美數位病理學市場規模將達到 6.939 億美元，2025 年至 2030 年的複合年成長率為 7.8%。

推動市場發展的主要因素是癌症等慢性疾病的日益普及。由於癌症發生率高，病理學家需要能夠為患者提供個人化治療的資料。因此，數位病理因其多種優勢逐漸被病理學家所選擇，包括加快診斷速度、提高診斷準確性以及提供治療建議以改善患者預後。

越來越多的合作協定旨在促進數位病理學在癌症診斷中的應用以及加速其發展，也是推動市場成長要素。近年來，人工智慧在數位病理學的應用日益受到重視。推動成長的因素包括降低醫療保健成本的需求不斷增加、巨量資料在醫療保健中的重要性日益增加、精準醫療的採用率不斷提高以及硬體成本下降。此外，醫療保健領域也擴大使用基於人工智慧的分析工具，以及該領域的大量資本投資進一步推動了市場的成長。

在冠狀病毒大流行期間，對家庭工作站和安全臨床資訊系統的需求激增，這些系統允許醫療保健專業人員遠端讀取影像並實現多學科護理團隊之間的虛擬協作。疫情期間，該地區各組織病理學部門都面臨人員減少、工作量增加的問題。數位病理學被視為病理學家面臨的一些挑戰的潛在解決方案，導致在冠狀病毒大流行期間更多地採用疾病的數位化診斷。

2020 年 4 月，飛利浦宣布 FDA 已批准其 IntelliSite Pathology Solution 消費者監測儀的家用緊急豁免。暫時取消遠端使用數位病理學的限制將有助於病理學家在家中獲取全幻燈片影像並加快組織學病例的診斷。在 COVID-19 之前，採用 DP 進行跨站點工作流程的病理實驗室報告協作得到改善，平均生產力提高了 21.0%，營運效率提高了 13.0%。預計這些舉措將推動市場成長。

北美數位病理市場報告重點

  • 北美數位病理學市場目前正在經歷顯著且加速的成長。
  • 2024 年，設備部門佔最大佔有率，為 52.07%。
  • 2024 年，人類病理學領域佔最大佔有率。
  • 對於 2024 年的預測期，學術研究領域將佔據市場主導地位。
  • 2024 年，美國數位病理學市場佔據各地區最大市場。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場分析
    • 輔助市場分析
  • 北美數位病理學市場-市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場問題分析
  • 北美數位病理學市場分析工具：波特五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代威脅
    • 來自新進入者的威脅
    • 競爭對手之間的競爭
  • PESTLE分析
    • 政治
    • 經濟與社會
    • 科技
    • 環境
    • 合法的
  • 使用案例和見解
  • COVID-19 的影響

第 4 章北美數位病理學市場：按產品分類的估計和趨勢分析

  • 北美數位病理學市場（按產品分類）：關鍵要點
  • 北美數位病理學市場：2024 年和 2030 年產品趨勢和市場佔有率分析
  • 軟體
  • 裝置
    • 掃描器
    • 幻燈片管理系統
  • 儲存系統

第5章北美數位病理學市場類型、估值與趨勢分析

  • 北美數位病理學市場（按類型）：關鍵要點
  • 北美數位病理學市場：2024 年和 2030 年類型趨勢和市場佔有率分析
  • 動物病理學
  • 人體病理學

第6章北美數位病理學市場：按應用的估計和趨勢分析

  • 北美數位病理學市場（按應用）關鍵要點
  • 北美數位病理學市場：2024 年和 2030 年應用趨勢和市場佔有率分析
  • 藥物研發
  • 學術研究
  • 疾病診斷
    • 癌細胞檢測
    • 其他

7. 北美數位病理學市場-最終用途、估計與趨勢分析

  • 北美數位病理學市場（按最終用途分類）：關鍵要點
  • 北美數位病理學市場：2024 年和 2030 年最終用途趨勢和市場佔有率分析
  • 醫院
  • 生物技術和製藥公司
  • 診斷實驗室
  • 學術研究所

第 8 章。北美數位病理學市場：按國家/地區分類的估計和趨勢分析

  • 北美數位病理學市場：2024 年和 2030 年區域趨勢分析
  • 區域市場儀表板
  • 區域市場概況
    • 北美洲

第9章競爭格局

  • 公司分類
  • 競爭性市場參與策略
  • 私人公司/供應商（按國家/地區）
  • 2024 年公司市場佔有率/地位分析
  • 公司簡介/上市公司
    • Leica Biosystems Nussloch GmbH（Danaher）
    • Hamamatsu Photonics, Inc
    • Koninklijke Philips NV
    • Olympus Corporation
    • F. Hoffmann-La Roche Ltd
    • Mikroscan Technologies, Inc
    • Inspirata, Inc.
    • Epredia（3DHISTECH Ltd.）
    • Huron Technologies International Inc.
    • CellaVision
    • Morphle Labs, Inc
    • Bionovation BIoTech, Inc
Product Code: GVR-4-68039-288-0

North America Digital Pathology Market Growth & Trends:

The North America digital pathology market size is expected to reach USD 693.9 million in 2030 and is expected to grow at a CAGR of 7.8% from 2025 to 2030. The market is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require data that facilitate personalizing therapy for patients. Hence, digital pathology is progressively being selected by pathologists as it has various benefits including accelerated diagnosis rate, diagnostic accuracy, and offers therapeutic recommendations to improve patient outcomes.

The growing number of collaborative agreements to develop as well as expedite the adoption of digital pathology in cancer diagnostics serves as a key growth factor contributing to the market. The use of artificial intelligence in digital pathology has gained momentum in the past years. The increasing need for lowering healthcare costs, increasing importance of big data in healthcare, rising adoption of precision medicine, and declining hardware costs are some factors driving the growth. In addition, increasing usage of artificial intelligence-based analytical tools in healthcare and high capital investments in this field are further propelling the market growth.

During the coronavirus outbreak, the exponential need for home-based workstations and safe clinical informatics systems allowing healthcare professionals to read images remotely and enabling virtual collaboration between their multi-disciplinary care teams has increased. Various histopathology departments in the region faced a reducing workforce and increasing workload during the pandemic. Digital pathology considered being the potential solution for some of the challenges faced by the pathologist, there is an increase in the adoption of digital diagnosis of disease during coronavirus outbreak.

In April 2020, Philips announced that the FDA granted a waiver for home use of consumer monitors with the company's IntelliSite Pathology Solution during the emergency. The temporary exemption of restrictions on remote use of the digital pathology helps pathologists to access whole slide images from home and fasten the diagnosis of histology cases. Some pathology labs that have adopted DP in their workflows across different sites pre-COVID-19, reported improved collaboration, and an average productivity gain of 21.0% with operation efficiency increased by 13.0%. These types of initiatives are anticipated to fuel market growth.

North America Digital Pathology Market Report Highlights:

  • North America digital pathology market is currently experiencing significant growth, at an accelerating pace
  • The device segment held the largest share of 52.07% in 2024
  • The human pathology segment held the largest share in 2024
  • The academic research segment dominated the market in 2024he forecast period
  • The digital pathology market in the U.S. dominated the regional market with the largest share in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database:
    • 1.3.2. Gvr's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research:
    • 1.3.5. Details Of Primary Research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for Primary Interviews in Europe
      • 1.3.5.3. Data for Primary Interviews in APAC
      • 1.3.5.4. Data for Primary Interviews in Latin America
      • 1.3.5.5. Data for Primary Interviews in MEA
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis
    • 1.6.2. Top Down Market Estimation
    • 1.6.3. CAGR Calculation
    • 1.6.4. Key Report Updates
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Report Objectives
    • 1.9.1. Objective - 1
    • 1.9.2. Objective - 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. North America Digital Pathology Market- Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Higher cost-efficiency
      • 3.2.1.3. Rapid technological advancements in the overall digital pathology market
        • 3.2.1.3.1. Competitive Factors and Strategies
        • 3.2.1.3.2. List of Top Notable Funded Digital Pathology Companies
        • 3.2.1.3.3. Top 10 Vendor - by Total Funding from 2014 - 2021 (Potential vendors for collabrations)
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of skilled professionals
      • 3.2.2.2. High cost of implementing digital pathology solutions
    • 3.2.3. Market Challenges Analysis
  • 3.3. North America Digital Pathology Market Analysis Tools: Porters Five Forces
    • 3.3.1. Bargaining power of the suppliers
    • 3.3.2. Bargaining power of the buyers
    • 3.3.3. Threats of substitution
    • 3.3.4. Threats from new entrants
    • 3.3.5. Competitive rivalry
  • 3.4. PESTLE Analysis
    • 3.4.1. Political landscape
    • 3.4.2. Economic and Social landscape
    • 3.4.3. Technological landscape
    • 3.4.4. Environmental landscape
    • 3.4.5. Legal landscape
  • 3.5. Case Studies & Inisghts
  • 3.6. Impact of COVID 19

Chapter 4. North America Digital Pathology Market: Product Estimates & Trend Analysis

  • 4.1. North America Digital Pathology Market, Product Type: Key Takeaways
  • 4.2. North America Digital Pathology Market: Product Type Movement & Market Share Analysis, 2024 & 2030
  • 4.3. Software
    • 4.3.1. Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Devices
    • 4.4.1. Devices Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. Scanners
      • 4.4.2.1. Scanners market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.4.3. Slide Management System
      • 4.4.3.1. Slide management system market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5. Storage Systems
    • 4.5.1. Storage Systems Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. North America Digital Pathology Market: Type Estimates & Trend Analysis

  • 5.1. North America Digital Pathology Market, by Type: Key Takeaways
  • 5.2. North America Digital Pathology Market: Type Movement & Market Share Analysis, 2024 & 2030
  • 5.3. Veterinary Pathology
    • 5.3.1. Veterinary Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Human Pathology
    • 5.4.1. Human Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. North America Digital Pathology Market: Application Estimates & Trend Analysis

  • 6.1. North America Digital Pathology Market, Application Type: Key Takeaways
  • 6.2. North America Digital Pathology Market: Application Movement & Market Share Analysis, 2024 & 2030
  • 6.3. Drug Discovery & Development
    • 6.3.1. Drug Discovery & Development Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Academic Research
    • 6.4.1. Academic Research Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Disease Diagnosis
    • 6.5.1. Disease Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Cancer Cell Detection
      • 6.5.2.1. Cancer Cell Detection Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Others
      • 6.5.3.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. North America Digital Pathology Market: End Use Estimates & Trend Analysis

  • 7.1. North America Digital Pathology Market, By End Use: Key Takeaways
  • 7.2. North America Digital Pathology Market: End Use Movement & Market Share Analysis, 2024 & 2030
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Biotech & Pharma Companies
    • 7.4.1. Biotech & Pharma Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Diagnostics Labs
    • 7.5.1. Diagnostics Labs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Academic & Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. North America Digital Pathology Market: Country Estimates & Trend Analysis

  • 8.1 North America Digital Pathology Market: Regional Movement Analysis, 2024 & 2030
  • 8.2 Regional Market Dashboard
  • 8.3 Regional Market Snapshot
    • 8.3.1 North America
      • 8.3.1.1 North America Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.2 U.S.
        • 8.3.1.2.1 Key Country Dynamics
        • 8.3.1.2.2 Competitive Scenario
        • 8.3.1.2.3 Regulatory Framework
        • 8.3.1.2.4 Reimbursement Scenario
        • 8.3.1.2.5 U.S. Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.3 Canada
        • 8.3.1.3.1 Key Country Dynamics
        • 8.3.1.3.2 Competitive Scenario
        • 8.3.1.3.3 Regulatory Framework
        • 8.3.1.3.4 Reimbursement Scenario
        • 8.3.1.3.5 Canada Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.4 Mexico
        • 8.3.1.4.1 Key Country Dynamics
        • 8.3.1.4.2 Competitive Scenario
        • 8.3.1.4.3 Regulatory Framework
        • 8.3.1.4.4 Reimbursement Scenario
        • 8.3.1.4.5 Mexico Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Competitive Market Entry Strategies
  • 9.3. Private Companies/ Vendors, By Country/Region
  • 9.4. Company Market Share/Position Analysis, 2024
  • 9.5. Company Profiles/Listing
    • 9.5.1. Leica Biosystems Nussloch GmbH (Danaher)
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Hamamatsu Photonics, Inc
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Koninklijke Philips N.V.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Olympus Corporation
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. F. Hoffmann-La Roche Ltd
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Mikroscan Technologies, Inc
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Inspirata, Inc.
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Epredia (3DHISTECH Ltd.)
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Huron Technologies International Inc.
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. CellaVision
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives
    • 9.5.11. Morphle Labs, Inc
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic Initiatives
    • 9.5.12. Bionovation Biotech, Inc
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Digital Pathology Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 8 North America Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 12 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Canada Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Mexico Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Mexico Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America Digital pathology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 North America Digital pathology market: Product movement analysis
  • Fig. 17 North America Digital pathology market: Product segment dashboard
  • Fig. 18 North America Digital pathology market product outlook: Key takeaways
  • Fig. 19 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Integrated Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Standalone Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Device market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Storage system market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 North America Digital pathology market: Type movement analysis
  • Fig. 25 North America Digital pathology market: Type segment dashboard
  • Fig. 26 North America Digital pathology market type outlook: Key takeaways
  • Fig. 27 Human digital pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Veterinary digital pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 North America Digital pathology market: Application movement analysis
  • Fig. 30 North America Digital pathology market: Application segment dashboard
  • Fig. 31 North America Digital pathology market application outlook: Key takeaways
  • Fig. 32 North America Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Academic research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Disease diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 North America Digital pathology market: End-use movement analysis
  • Fig. 36 North America Digital pathology market: End-use segment dashboard
  • Fig. 37 North America Digital pathology market end-use outlook: Key takeaways
  • Fig. 38 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Biotech & pharma companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Academic &research institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Regional outlook, 2024 & 2030
  • Fig. 43 Regional market dashboard
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 North America, SWOT
  • Fig. 46 North America Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 48 Canada Digital pathology market, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico Digital pathology market, 2018 - 2030 (USD Million)